Abstract
APOBEC3 signature mutations in chronic lymphocytic leukemia.
Highlights
7 Østgård L, Nørgaard J, Sengeløv H, Severinsen M, Friis L, Marcher C et al Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study, March 2014 (under submission)
APOBEC1 deaminates the mRNA for Apolipoprotein B thereby generating ApoB48, which mediates the absorption of dietary lipid from the intestine.[3]
In chronic lymphocytic leukemia (CLL), previous reports have described the presence of activation-induced deaminase (AID) transcripts in a subset of CLL patients where AID-expressing
Summary
7 Østgård L, Nørgaard J, Sengeløv H, Severinsen M, Friis L, Marcher C et al Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study, March 2014 (under submission). 14 Gangatharan SA, Grove CS, P’ng S, O’Reilly J, Joske D, Leahy MF et al Acute myeloid leukaemia in Western Australia 1991–2005: a retrospective population-based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have